Trump tells Pentagon to immediately resume testing US nuclear weapons

President Donald Trump ordered the U.S. military to immediately resume nuclear weapons testing after a 33-year hiatus, citing testing programs by rival nuclear powers and China's expanding arsenal. This directive, announced via Truth Social, aims to put the U.S. on an "equal basis" with other nuclear nations, despite Russia clarifying its recent tests involved nuclear-powered, not nuclear-explosive, weapons. The move drew swift international condemnation from China, the UN, and arms control experts, who warned it could destabilize global non-proliferation efforts and trigger a new arms race, ending a long-standing moratorium.

Analysis

President Trump's directive to immediately resume U.S. nuclear weapons testing after a 33-year hiatus signals a significant shift in global nuclear policy. This decision, announced via Truth Social, is explicitly aimed at achieving an "equal basis" with other nuclear powers, citing China's projected arsenal expansion from 300 warheads in 2020 to over 1,000 by 2030, and Russia's recent nuclear-powered weapon tests.

The announcement has elicited strong international condemnation and skepticism. Russia clarified its recent tests involved nuclear-powered, not nuclear-explosive, weapons, while China's Foreign Ministry urged adherence to the nuclear testing moratorium. Arms control experts, such as Daryl Kimball, warned that resuming tests could trigger a dangerous chain reaction, undermine the Nuclear Non-Proliferation Treaty, and destabilize global security.

This move significantly elevates geopolitical tensions, particularly with China and Russia, and introduces considerable uncertainty into international arms control frameworks. The strongly negative general sentiment score of -0.7 and a market impact score of 0.7 reflect investor concerns regarding potential escalation and instability, which could influence defense sector spending and risk premiums across global markets.

Key Decisions for Investors

• Monitor geopolitical developments closely, particularly any retaliatory actions or further escalations from nuclear powers that could impact global stability.
• Assess potential impacts on defense sector investments, considering increased spending on nuclear infrastructure and related technologies, while also factoring in political and legislative opposition.
• Evaluate the risk premium associated with heightened global political instability, potentially adjusting portfolio allocations towards defensive assets or those less exposed to geopolitical shocks.
• Watch for legislative efforts to counter the directive, as indicated by Representative Titus, which could introduce domestic policy uncertainty and influence the feasibility of resuming tests.